Wang W, Shi Y, Yan B, Cai Y, Zheng H, Zhang Y
Sci Rep. 2024; 14(1):30796.
PMID: 39730581
PMC: 11680814.
DOI: 10.1038/s41598-024-81192-6.
Elkhadragy L, Myers A, Long W
Cancers (Basel). 2024; 16(7).
PMID: 38611058
PMC: 11011113.
DOI: 10.3390/cancers16071381.
Liu H, Tang T
Sci Rep. 2023; 13(1):19055.
PMID: 37925483
PMC: 10625624.
DOI: 10.1038/s41598-023-45774-0.
Zhou J, Xiang H, Cao Z
Front Oncol. 2023; 13:1253191.
PMID: 37829341
PMC: 10565035.
DOI: 10.3389/fonc.2023.1253191.
Knowles T, Huang T, Qi J, An S, Burket N, Cooper S
Cancers (Basel). 2023; 15(12).
PMID: 37370851
PMC: 10296230.
DOI: 10.3390/cancers15123241.
An Insight into the microRNAs Associated with Arteriovenous and Cavernous Malformations of the Brain.
Florian I, Buruiana A, Timis T, Susman S, Florian I, Balasa A
Cells. 2021; 10(6).
PMID: 34199498
PMC: 8227573.
DOI: 10.3390/cells10061373.
Let-7i-5p enhances cell proliferation, migration and invasion of ccRCC by targeting HABP4.
Liu Y, Hu X, Hu L, Xu C, Liang X
BMC Urol. 2021; 21(1):49.
PMID: 33775245
PMC: 8005230.
DOI: 10.1186/s12894-021-00820-9.
Multi-Level Regulatory Interactions between NF-κB and the Pluripotency Factor Lin28.
Mills 4th W, Nassar N, Ravindra D, Li X, Meffert M
Cells. 2020; 9(12).
PMID: 33348917
PMC: 7767241.
DOI: 10.3390/cells9122710.
Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer.
Zhao Z, Li Y, Liu H, Jain A, Patel P, Cheng K
Sci Adv. 2020; 6(29):eabb0616.
PMID: 32832636
PMC: 7439402.
DOI: 10.1126/sciadv.abb0616.
The lncRNA H19 binding to let-7b promotes hippocampal glial cell activation and epileptic seizures by targeting Stat3 in a rat model of temporal lobe epilepsy.
Han C, Liu Y, Guo C, Du T, Jiang Y, Wang K
Cell Prolif. 2020; 53(8):e12856.
PMID: 32648622
PMC: 7445408.
DOI: 10.1111/cpr.12856.
MicroRNA-mRNA Interactions at Low Levels of Compressive Solid Stress Implicate mir-548 in Increased Glioblastoma Cell Motility.
Calhoun M, Cui Y, Elliott E, Mo X, Otero J, Winter J
Sci Rep. 2020; 10(1):311.
PMID: 31941933
PMC: 6962377.
DOI: 10.1038/s41598-019-56983-x.
Nuclear Factor κB Signaling and Its Related Non-coding RNAs in Cancer Therapy.
Liu X, Shao Y, Zhou J, Qian G, Ma Z
Mol Ther Nucleic Acids. 2019; 19:208-217.
PMID: 31841993
PMC: 6920321.
DOI: 10.1016/j.omtn.2019.11.007.
Advances in IKBKE as a potential target for cancer therapy.
Yin M, Wang X, Lu J
Cancer Med. 2019; 9(1):247-258.
PMID: 31733040
PMC: 6943080.
DOI: 10.1002/cam4.2678.
Advancing towards Effective Glioma Therapy: MicroRNA Derived from Umbilical Cord Mesenchymal Stem Cells' Extracellular Vesicles.
Ngadiono E, Silvia Hardiany N
Malays J Med Sci. 2019; 26(4):5-16.
PMID: 31496889
PMC: 6719885.
DOI: 10.21315/mjms2019.26.4.2.
let-7i inhibits proliferation and migration of bladder cancer cells by targeting HMGA1.
Qin M, Chai X, Huang H, Feng G, Li X, Zhang J
BMC Urol. 2019; 19(1):53.
PMID: 31196036
PMC: 6567622.
DOI: 10.1186/s12894-019-0485-1.
Expression-based decision tree model reveals distinct microRNA expression pattern in pediatric neuronal and mixed neuronal-glial tumors.
Zakrzewska M, Gruszka R, Stawiski K, Fendler W, Kordacka J, Grajkowska W
BMC Cancer. 2019; 19(1):544.
PMID: 31170943
PMC: 6555720.
DOI: 10.1186/s12885-019-5739-5.
Decreased let-7b is associated with poor prognosis in glioma.
Zhang W, Zhao W, Ge C, Li X, Yang X, Xiang Y
Medicine (Baltimore). 2019; 98(22):e15784.
PMID: 31145301
PMC: 6709123.
DOI: 10.1097/MD.0000000000015784.
MCCK1 enhances the anticancer effect of temozolomide in attenuating the invasion, migration and epithelial-mesenchymal transition of glioblastoma cells in vitro and in vivo.
Liu T, Li A, Xu Y, Xin Y
Cancer Med. 2019; 8(2):751-760.
PMID: 30656846
PMC: 6382719.
DOI: 10.1002/cam4.1951.
Glioblastoma Exosomes for Therapeutic Angiogenesis in Peripheral Ischemia.
Monteforte A, Lam B, Sherman M, Henderson K, Sligar A, Spencer A
Tissue Eng Part A. 2017; 23(21-22):1251-1261.
PMID: 28699397
PMC: 5689131.
DOI: 10.1089/ten.TEA.2016.0508.
IKBKE regulates cell proliferation and epithelial-mesenchymal transition of human malignant glioma via the Hippo pathway.
Lu J, Yang Y, Guo G, Liu Y, Zhang Z, Dong S
Oncotarget. 2017; 8(30):49502-49514.
PMID: 28548934
PMC: 5564784.
DOI: 10.18632/oncotarget.17738.